Human Photoallergy Test
NCT02750449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2018-12-13
Summary
To evaluate the potential of a test material to produce a photo allergic response.
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
Sun screening Sport Lotion, (BAY987516)
50 μl/ cm\*2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. 24 hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3 μl/ cm\*2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. 48 hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures. (Formulation Number - RB# Y65-110)
- OTHER
-
Untreated skin
This site is patched without treatment as control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-09
- Primary Completion
- 2016-07-01
- Completion
- 2016-07-01
Countries
- United States
Study Locations
More Related Trials
-
Human Photoallergy Test
NCT02751515 ·Status: COMPLETED ·Phase: NA
-
18348-Human Phototoxicity Test
NCT02823483 ·Status: COMPLETED ·Phase: NA
-
To Test for Photo Allergy Reaction of Sunscreens
NCT02872220 ·Status: COMPLETED ·Phase: NA
-
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Photo Allergic Skin Reaction
NCT04070755 ·Status: COMPLETED ·Phase: PHASE1
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Photopatch Test Study (POST Study)
NCT03812887 ·Status: UNKNOWN
-
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996 ·Status: RECRUITING ·Phase: NA
-
Substance P Challenge in Healthy Participants
NCT04676763 ·Status: COMPLETED ·Phase: NA
-
SPT for Sensitization of Collagen Dressing
NCT06271993 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
NCT02117752 ·Status: COMPLETED ·Phase: PHASE1
-
The Frequency of Positive Challenge Test to Penicillin in Children Suspected to Have Allergy to Penicillin
NCT02702349 ·Status: UNKNOWN ·Phase: NA
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
Diagnosing Drug Allergy: the T is the Key
NCT06409884 ·Status: RECRUITING ·Phase: NA
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1
-
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels
NCT06755281 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
NCT00795951 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Challenges Without Prior Skin Testing
NCT03158831 ·Status: COMPLETED ·Phase: PHASE1